OBSTETRİDE YAYGIN DAMAR İÇİ KOAGÜLASYON: ETYOPATOGENEZ VE GÜNCEL TEDAVİ STRATEJİLERİ

TETİK, Şermin; ŞAHİN, Sadık; EROĞLU, MUSTAFA; GÜZİN, Kadir

OBSTETRİDE YAYGIN DAMAR İÇİ KOAGÜLASYON: ETYOPATOGENEZ VE GÜNCEL TEDAVİ STRATEJİLERİ

Sadık ŞAHİN, (Zeynep Kamil Kadın Doğum ve Çocuk Hastalıkları Eğitim ve Araştırma Hastanesi, İstanbul, Türkiye)

Mustafa EROĞLU, (Zeynep Kamil Kadın Doğum ve Çocuk Hastalıkları Eğitim ve Araştırma Hastanesi, İstanbul, Türkiye)

Şermin TETİK, (Marmara Üniversitesi, Eczacılık Fakültesi, Biyokimya Anabilim Dalı, İstanbul, Türkiye)

Kadir GÜZİN (Medeniyet Üniversitesi, Göztepe Eğitim ve Araştırma Hastanesi, Kadın Hastalıkları ve Doğum Bölümü, İstanbul, Türkiye)

Türk Jinekoloji ve Obstetrik Derneği Dergisi

3 1

Yıl: 2014 Cilt: 11 Sayı: 1 Sayfa Aralığı: 42 - 51 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

OBSTETRİDE YAYGIN DAMAR İÇİ KOAGÜLASYON: ETYOPATOGENEZ VE GÜNCEL TEDAVİ STRATEJİLERİ

Öz:

Obstetrik nedenlere bağlı olarak gelişen yaygın damar içi koagülasyon, nadir görülmesine rağmen morbidite ve mortalitesi oldukça yüksek seyreden klinik bir durumdur. Günümüzde yaygın damar içi koagülasyonun patofizyolojisi tam olarak aydınlatılamamış olup, bu nedenle etkili ve kalıcı tedavi yöntemleri henüz geliştirilememiştir. Bu derlemede, klinisyenin bakış açısıyla obstetrik pratikte karşımıza çıkan yaygın damar içi koagülasyon değerlendirilmiş ve güncel literatür bilgisi ışığında yaygın damar içi koagülasyonun etyopatogenezi, tanısal yaklaşımları ve tedavi alternatişeri tartışılmıştır

Anahtar Kelime:

Konular: Cerrahi

DISSEMINATED INTRAVASCULAR COAGULATION IN OBSTETRICS: ETIOPATHOGENESIS AND UP TO DATE MANAGEMENT STRATEGIES SUMMARY

Öz:

Disseminated intravascular coagulation related to obstetric conditions is rarely seen but is associated with high morbidity and mortality. Recently, pathophysiology of disseminated intravascular coagulation has not been understood well and, therefore, effective and permanent treatment strategies are missing. In this review, we try to discuss the etiology, current diagnostic approaches and management strategies of disseminated intravascular coagulation from the perspectives of clinicians.

Anahtar Kelime:

Konular: Cerrahi

Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık

1. Williams J, Mozurkewich E, Chilimigras J, Van De Ven C. Critical care in obstetrics: pregnancy-specific conditions. Best Pract Res Clin Obstet Gynaecol 2008;22(5):825-46.
2. DeLee JB. A case of fatal hemorrhagic diathesis, with premature detachment of the placenta. Am J Obstet Dis Women Child 1901;44:785-92.
3. Bick RL. Disseminated intravascular coagulation: a review of etiology, pathophysiology, diagnosis, and management: guidelines for care. Clin Appl Thromb Hemost 2002;8(1): 1-31.
4. Bick RL. Disseminated intravascular coagulation current concepts of etiology, pathophysiology, diagnosis, and treatment. Hematol Oncol Clin North Am 2003;17(1):149-76.
5. Bick RL. Syndromes of disseminated intravascular coagulation in obstetrics, pregnancy, and gynecology. Objective criteria for diagnosis and management. Hematol Oncol Clin North Am 2000;14(5):999-1044.
6. Liang BL, Hong DH. Diagnosis and management of obstetric acute disseminated intravascular coagulation. Zhonghua Fu Chan Ke Za Zhi 1992;27(3):147-9, 188.
7. Kor-anantakul O, Lekhakula A. Overt disseminated intravascular coagulation in obstetric patients. J Med Assoc Thai 2007;90(5):857-64.
8. Rattray DD, O'Connell CM, Baskett TF. Acute disseminated intravascular coagulation in obstetrics: A tertiary centre population review (1980 to 2009). J Obstet Gynaecol Can 2012;34(4):341-7.
9. Kobayashi T, Terao T, Maki M, Ikenoue T. Diagnosis and management of acute obstetrical DIC. Semin Thromb Hemost 2001;27(2):161-7.
10. Oyelese Y, Ananth CV. Placental abruption. Obstet Gynecol 2006;108(4):1005-16.
11. Kramer MS, Usher RH, Pollack R et al. Etiologic determinants of abruptio placentae. Obstet Gynecol 1997;89(2):221-6.
12. Han CS, Schatz F, Lockwood CJ. Abruption-associated prematurity. Clin Perinatol 2011;38(3):407-21.
13. Ananth CV, Getahun D, Peltier MR et al. Placental abruption in term and preterm gestations: evidence for heterogeneity in clinical pathways. Obstet Gynecol 2006;107(4):785-92.
14. Hess JR. Blood and coagulation support in trauma care. Hematol Am Soc Hematol Educ Program 2007;187-91.
15. Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999;180(2 Pt 1):499-506.
16. Savvidou MD, Hingorani AD, Tsikas D et al. Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia. Lancet 2003;361(9368):1511- 7.
17. Redman CW. Platelets and the beginnings of preeclampsia. N Engl J Med 1990;323(7):478-80.
18. Martin JN, Rose CH, Briery CM. Understanding and managing HELLP syndrome: the integral role of aggressive glucocorticoids for mother and child. Am J Obstet Gynecol 2006;195(4):914-34.
19. Fang CJ, Richards A, Liszewski MK, et al. Advances in understanding of pathogenesis of HUS and HELLP. Br J Haematol 2008;143(3):336-48.
20. Boisramé-Helms J, Kremer H, Schini-Kerth V, Meziani F. Endothelial dysfunction in sepsis. Curr Vasc Pharmacol 2013; 11(2):150-60.
21. Högberg U, Joelsson I. Amniotic fluid embolism in Sweden, 1951-1980. Gynecol Obstet Invest 1985;20(3):130-7.
22. Clark SL, Hankins GD, Dudley DA, Dildy GA, Porter TF. Amniotic fluid embolism: analysis of the national registry. Am J Obstet Gynecol 1995;172(4 Pt 1):1158- 67.
23. Yang W, Zhou N, Zhou Y. The clinical analysis of 38 cases with amniotic fluid embolism [Chinese]. Zhonghua Fu Chan Ke Za Zhi 2000;35(2):75-8.
24. Abenhaim HA, Azoulay L, Kramer MS, Leduc L. Incidence and risk factors of amniotic fluid embolisms: a populationbased study on 3 million births in the United States. Am J Obstet Gynecol 2008;199(1):49.e1-8.
25. Sullivan EA, King JF. Maternal deaths in Australia 2000- 2002. Maternal deaths series no. 2. Cat. no. PER 32. Sydney: AIHW National Perinatal Statistics Unit; 2006.
26. Lewis G. The confidential enquiry into maternal and child health (CEMACH). Saving mothers' lives: reviewing maternal deaths to make motherhood safer-2002-2005. The seventh report on confidential enquiries into maternal deaths in the United Kingdom. London: CEMACH; 2007.
27. Dey M, Reema K. Acute fatty liver of pregnancy. N Am J Med Sci 2012;4(11):611-2.
28. Bacq Y. Acute fatty liver of pregnancy. Semin Perinatol 1998; 22(2):134-40.
29. Castro MA, Goodwin MT, Shaw KJ, et al. Disseminated intravascular coagulation and antithrombin III depression in acute fatty liver of pregnancy. Am J Obstet Gynecol 1996; 174(1 Pt 1):211-6.
30. Hoffman M, Monroe DM. Coagulation 2006: a modern view of hemostasis. Hematol Oncol Clin North Am 2007;21(1):1-11.
31. Tetik S, Kaya K, Yardimci T. Effect of oxidized fibrinogen on haemostatic system: in vitro study. Clin Appl Thromb Hemost 2011;17(3):259-63.
32. Bremme KA. Haemostatic changes in pregnancy. Best Pract Res Clin Haematol 2003;16(2):153-68.
33. DahlmanT, Hellgren M, Blomback M. Changes in blood coagulation and fibrinolysis in the normal puerperium. Gynecol Obstet Invest 1985;20(1):37-44.
34. O'Riordan MN, Higgins JR. Haemostasis in normal and abnormal pregnancy. Best Pract Res Clin Obstet Gynaecol 2003;17(3):385-96.
35. Tetik S, Ak K, Sahin Y, Isbir S, Gulsoy O, Arsan S, Yardimci T. Postoperative statin therapy attenuates the intensity of systemic inflammation and increases fibrinolysis after coronary artery bypass grafting. Clin Appl Thromb Hemost 2011;17(5): 526-31.
36. Levi M, Toh CH, Thachil J, Watson HG. Guidelines for the diagnosis and management of disseminated intravascular coagulation: British Committee for Standards in Haematology. Br J Haematol 2009;145(1):24-33.
37. Gando S, Iba T, Eguchi Y et al. A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria. Crit Care Med 2006;34(3):625-31.
38. Çakmakç M. Abdominal kompartman sendromu. T Klinikleri Cerrahi Dergisi 1998;3:51-4.
39. Ak K, Isbir C, Tetik S, Atalan N, Tekeli A, Aljodi M et al. Thromboelastography based transfusion algorithm reduces blood product use after elective CABG: A prospective randomized study. J Card Surg 2009;24(4):404-10.
40. Tetik fi, Ak K, Yardmc KT. The factors effecting platelet function tests. Cumhuriyet Tp Der 2012;4:123-7.
41. Bick RL, Baker WF. Diagnostic efficacy of the D-dimer assay in disseminated intravascular coagulation (DIC). Thrombosis Research 1992;65(6):785-90.
42. Al-Mondhiry. Disseminated intravascular coagulation: experience in a major cancer center. Thrombosis et Diathesis Haemorrhagica 1975;34(1):181-93.
43. Siegal T, Seligsohn U, Aghai E Modan M. Clinical and laboratory aspects of disseminated intravascular coagulation (DIC): a study of 118 cases. J Thromb Haemost 1978;39(1): 122-34.
44. Mant MJ, King EG. Severe, acute disseminated intravascular coagulation. A reappraisal of its pathophysiology, clinical significance and therapy based on 47 patients. Am J Medicine 1979;67:557-63.
45. Spero JA, Lewis JH, Hasiba U. Disseminated intravascular coagulation. Findings in 346 patients. J Thromb Haemost 1980;43(1):28-33.
46. Wilde JT, Kitchen S, Kinsey S, Greaves M, Preston FE. Plasma D-dimer levels and their relationship to serum fibrinogen/fibrin degradation products in hypercoagulable states. Br J Haematol 1989;71(1):65-70.
47. Neame PB, Kelton JG, Walker IR, Stewart IO, Nossel HL, Hirsh, J. Thrombocytopenia in septicemia: the role of disseminated intravascular coagulation. Blood 1980;56(1): 88-92.
48. Akca S, Haji-Michael P, de MA, Suter P, Levi M, Vincent JL. Time course of platelet counts in critically ill patients. Crit Care Med 2002;30(4):753-6.
49. Carr, J.M., McKinney, M. & McDonagh, J. Diagnosis of disseminated intravascular coagulation. Role of D-dimer. Am J Clin Pathol 1989;91(3):280-7.
50. Bick, R.L. Disseminated intravascular coagulation: objective clinical and laboratory diagnosis, treatment, and assessment of therapeutic response. Semin Thromb Hemost 1996;22(1): 69-88.
51. Asakura H, Ontachi Y, Mizutani T, Kato M., Ito T, Saito M. Decreased plasma activity of antithrombin or protein C is not due to consumption coagulopathy in septic patients with disseminated intravascular coagulation. Eur J Haematol 2001; 67(3):170-5.
52. Levi M, Ten CH. Disseminated intravascular coagulation. N Engl J Med 1999;341(8):586-92.
53. Levi, M., de, J.E., van der, P.T. & Ten, C.H. Disseminated intravascular coagulation. J Thromb Haemost 1999;82(2): 695-705.
54. O'Riordan MN, Higgins JR. Haemostasis in normal and abnormal pregnancy. Best Pract Res Clin Obstet Gynaecol 2003;17(3):385-96.
55. Wallenburg HC, van Kessel PH. Platelet lifespan in normal pregnancy as determined by a non-radioisotopic technique. BJOG 1978;85(1):33-6.
56. Neame PB, Kelton JG, Walker IR, et al. Thrombocytopenia in septicemia: the role of disseminated intravascular coagulation. Blood 1980;56(1):88-92.
57. Manten GT, Franx A, Sikkema JM, et al. Fibrinogen and high molecular weight fibrinogen during and after normal pregnancy. Thromb Res 2004;114(1):19-23.
58. Charbit B, Mandelbrot L, Samain E . The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost 2007;5(2):266-73.
59. Nieuwenhuizen W. A reference material for harmonisation of D-dimer assays. Thromb Haemost 1997;77(5):1031-3.
60. Tetik fi, Ak K. Platelet function tests on cardiovascular dieases: from pathophysiology to clinical approach. Cumhuriyet Med J 2010;32:264-74.
61. Sharma P, Saxena R. A novel thromboelastographic score to identify overt disseminated intravascular coagulation resulting in a hypocoagulable state. Am J Clin Pathol 2010;134(1):97-102.
62. Taylor FB, Toh CH, Hoots WK, Wada H, Levi M. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. J Thromb Hemost 2001;86(5):1327-30.
63. Gando S, Wada H, Asakura H, Iba T, Eguchi Y, Okamoto K. Evaluation of new Japanese diagnostic criteria for disseminated intravascular coagulation in critically ill patients. Clin Appl Thromb Hemost 2005;11(1):71-6.
64. Bakhtiari K, Meijers JC, Levi M. Prospective validation of the international society of thrombosis and haemostasis scoring system for disseminated intravascular coagulation. Crit Care Med 2004;32(12):2416-21.
65. Thachil J, Toh CH. Disseminated intravascular coagulation in obstetric disorders and its acute haematological management. Blood Rev 2009;23(4):167-76.
66. Josic D, Hoffer L, Buchacher A. Manufacturing of a prothrombin complex concentrate aiming at low thrombogenicity. Thromb Res 2000;100(5):433-41.
67. Preston FE, Laidlaw ST, Sampson B. Rapid reversal of oral anticoagulation with warfarin by a prothrombin complex concentrate (Beriplex): efficacy and safety in 42 patients. Br J Haematol 2002;116(3):619-24.
68. Kreuz W, Meili E, Peter-Salonen K. Efficacy and tolerability of a pasteurised human fibrinogen concentrate in patients with congenital fibrinogen deficiency. Transfus Apher Sci 2005; 32(3):247-53.
69. Weinkove R, Rangarajan S. Fibrinogen concentrate for acquired hypofibrinogenaemic states. Transfus Med 2008;18(3):151-7.
70. Wise A, Clark V. Strategies to manage major obstetric haemorrhage. Curr Opin Anaesthesiol 2008;21(3):281-7.
71. Kayabasoglu F, Guzin K, Aydogdu S, Sezginsoy S, Turkgeldi L, Gunduz G. Emergency peripartum hysterectomy in a tertiary Istanbul hospital. Arch Gynecol Obstet 2008;278(3):251-6.
72. Stainsby D, MacLennan S, Thomas D, Isaac J, Hamilton PJ. BCSH guidelines on the management of massive blood loss. Br J Haematol 2006;135(5):634-41.
73. Van der Linden P, Ickx BE. The effects of colloid solutions on hemostasis. Can J Anaesth 2006;53(6 Suppl):S30-9.
74. Hirshberg A, Dugas M, Banez E, Scott B, Wall M, Mattox K. Minimizing dilutional coagulopathy in exanguinating hemorrhage: a computer simulation. J Trauma 2003;54(3): 454-61.
75. Malone DL, Hess JR, Fingerhut A. Massive transfusion practices around the globe and a suggestion for a common massive transfusion protocol. J Trauma 2006;60(6 Suppl):S91- 6.
76. Borgman MA, Spinella PC, Perkins JG, et al. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma 2007;63(4):805-13.
77. Johansson PI, Stensballe J, Rosenberg I, et al. Proactive administration of platelets and plasma for patients with a ruptured abdominal aortic aneurysm: evaluating a change in transfusion practice. Transfusion 2007;47(4):593-8.
78. Fenger-Eriksen C, Lindberg-Larsen M, Christensen AQ, et al. Fibrinogen concentrate substitution therapy in patients with massive haemorrhage and low plasma fibrinogen concentrations. Br J Anaesth 2008;101(6):769-73.
79. Wikkelsoe AJ, Afshari A, Stensballe J, Langhoff-Roos J, Albrechtsen C et al. The FIB-PPH trial: fibrinogen concentrate as initial treatment for postpartum haemorrhage: study protocol for a randomised controlled trial. Trials 2012;13:110.
80. Meng ZH, Wolberg AS, Monroe 3rd DM. The effect of temperature and pH on the activity of factor VIIa: implications for the efficacy of high-dose factor VIIa in hypothermic and acidotic patients. J Trauma 2003;55(5):886-91.
81. Gabriel A, Li X, Monroe DM. Recombinant human factor VIIa, (rFVIIa) can activate FX on activated platelets. J Thromb Haemost 2004;2(10):1816-22.
82. Sobieszczyk S, Breborowicz GH, Platicanov V, et al. Recombinant factor VIIa in the management of postpartum bleeds: an audit of clinical use. Acta Obstet Gynecol Scand 2006;85(10):1239-47.
83. Franchini M, Lippi G, Franchi M. The use of recombinant activated factor VII in obstetric and gynaecological haemorrhage. BJOG 2007;114(1):8-15.
84. Haynes J, Laffan M, Plaat F. Use of recombinant activated factor VII in massive obstetric haemorrhage. Int J Obstet Anesth 2007;16(1):40-9.
85. Butwick AJ. Postpartum hemorrhage and low fibrinogen levels: the past, present and future. Int J Obstet Anesth 2013; 22(2):87-91.
86. Novikova N, Hofmeyr GJ. Tranexamic acid for preventing postpartum haemorrhage. Cochrane Database Syst Rev 2010; (7):CD007872.

APA	ŞAHİN S, EROĞLU M, TETİK Ş, GÜZİN K (2014). OBSTETRİDE YAYGIN DAMAR İÇİ KOAGÜLASYON: ETYOPATOGENEZ VE GÜNCEL TEDAVİ STRATEJİLERİ. , 42 - 51.
Chicago	ŞAHİN Sadık,EROĞLU MUSTAFA,TETİK Şermin,GÜZİN Kadir OBSTETRİDE YAYGIN DAMAR İÇİ KOAGÜLASYON: ETYOPATOGENEZ VE GÜNCEL TEDAVİ STRATEJİLERİ. (2014): 42 - 51.
MLA	ŞAHİN Sadık,EROĞLU MUSTAFA,TETİK Şermin,GÜZİN Kadir OBSTETRİDE YAYGIN DAMAR İÇİ KOAGÜLASYON: ETYOPATOGENEZ VE GÜNCEL TEDAVİ STRATEJİLERİ. , 2014, ss.42 - 51.
AMA	ŞAHİN S,EROĞLU M,TETİK Ş,GÜZİN K OBSTETRİDE YAYGIN DAMAR İÇİ KOAGÜLASYON: ETYOPATOGENEZ VE GÜNCEL TEDAVİ STRATEJİLERİ. . 2014; 42 - 51.
Vancouver	ŞAHİN S,EROĞLU M,TETİK Ş,GÜZİN K OBSTETRİDE YAYGIN DAMAR İÇİ KOAGÜLASYON: ETYOPATOGENEZ VE GÜNCEL TEDAVİ STRATEJİLERİ. . 2014; 42 - 51.
IEEE	ŞAHİN S,EROĞLU M,TETİK Ş,GÜZİN K "OBSTETRİDE YAYGIN DAMAR İÇİ KOAGÜLASYON: ETYOPATOGENEZ VE GÜNCEL TEDAVİ STRATEJİLERİ." , ss.42 - 51, 2014.
ISNAD	ŞAHİN, Sadık vd. "OBSTETRİDE YAYGIN DAMAR İÇİ KOAGÜLASYON: ETYOPATOGENEZ VE GÜNCEL TEDAVİ STRATEJİLERİ". (2014), 42-51.

APA	ŞAHİN S, EROĞLU M, TETİK Ş, GÜZİN K (2014). OBSTETRİDE YAYGIN DAMAR İÇİ KOAGÜLASYON: ETYOPATOGENEZ VE GÜNCEL TEDAVİ STRATEJİLERİ. Türk Jinekoloji ve Obstetrik Derneği Dergisi, 11(1), 42 - 51.
Chicago	ŞAHİN Sadık,EROĞLU MUSTAFA,TETİK Şermin,GÜZİN Kadir OBSTETRİDE YAYGIN DAMAR İÇİ KOAGÜLASYON: ETYOPATOGENEZ VE GÜNCEL TEDAVİ STRATEJİLERİ. Türk Jinekoloji ve Obstetrik Derneği Dergisi 11, no.1 (2014): 42 - 51.
MLA	ŞAHİN Sadık,EROĞLU MUSTAFA,TETİK Şermin,GÜZİN Kadir OBSTETRİDE YAYGIN DAMAR İÇİ KOAGÜLASYON: ETYOPATOGENEZ VE GÜNCEL TEDAVİ STRATEJİLERİ. Türk Jinekoloji ve Obstetrik Derneği Dergisi, vol.11, no.1, 2014, ss.42 - 51.
AMA	ŞAHİN S,EROĞLU M,TETİK Ş,GÜZİN K OBSTETRİDE YAYGIN DAMAR İÇİ KOAGÜLASYON: ETYOPATOGENEZ VE GÜNCEL TEDAVİ STRATEJİLERİ. Türk Jinekoloji ve Obstetrik Derneği Dergisi. 2014; 11(1): 42 - 51.
Vancouver	ŞAHİN S,EROĞLU M,TETİK Ş,GÜZİN K OBSTETRİDE YAYGIN DAMAR İÇİ KOAGÜLASYON: ETYOPATOGENEZ VE GÜNCEL TEDAVİ STRATEJİLERİ. Türk Jinekoloji ve Obstetrik Derneği Dergisi. 2014; 11(1): 42 - 51.
IEEE	ŞAHİN S,EROĞLU M,TETİK Ş,GÜZİN K "OBSTETRİDE YAYGIN DAMAR İÇİ KOAGÜLASYON: ETYOPATOGENEZ VE GÜNCEL TEDAVİ STRATEJİLERİ." Türk Jinekoloji ve Obstetrik Derneği Dergisi, 11, ss.42 - 51, 2014.
ISNAD	ŞAHİN, Sadık vd. "OBSTETRİDE YAYGIN DAMAR İÇİ KOAGÜLASYON: ETYOPATOGENEZ VE GÜNCEL TEDAVİ STRATEJİLERİ". Türk Jinekoloji ve Obstetrik Derneği Dergisi 11/1 (2014), 42-51.